FIELD: medicine.
SUBSTANCE: group of inventions relates to anti-retinochoroidal disorder drugs. Method of preventing or treating a retinochoroidal disorder, in particular a method for preventing or reducing scar formation on the retina and/or choroid in a subject, comprises administering to said subject palovarotene ((E)-4-(2-{3-[(1H-pyrazol-1-yl)methyl]-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl}vinyl)benzoic acid) in an amount effective for treatment.
EFFECT: group of inventions provides effective treatment of retinochoroidal disorders by inhibiting collagen atrophy of retinal pigment epithelial cells, fibroblasts, glial cells.
26 cl, 2 dwg, 3 ex
